Syncom Formulations (India) Limited (BOM: 524470)
India flag India · Delayed Price · Currency is INR
25.84
-0.93 (-3.47%)
At close: Sep 10, 2024

Syncom Formulations (India) Company Description

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India.

It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments.

The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations.

It also provides life care, evolve, and right nutrition products under the Cratus brand. In addition, the company engages in the trading of commodities and renting of properties.

It also exports its products. The company offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent.

Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.

Syncom Formulations (India) Limited
Country India
Founded 1988
Industry Pharmaceutical Preparations
Employees 555
CEO Vijay Bankda

Contact Details

Address:
Syncom House
Indore, 452018
India
Phone 91 73 1270 0458
Website syncomformulations.com

Stock Details

Ticker Symbol 524470
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Vijay Bankda Chief Executive Officer
Ankit Bankda Chief Financial Officer